<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>13</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wim Van Molle</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Round table discussion</style></title><secondary-title><style face="normal" font="default" size="100%">Human Infection Studies Considerations on manufacturing of challenge agents- viruses (SARS-CoV-2/COVID-19) and parasites as examples  A Joint Wellcome Trust/HIC-Vac, hVIVO and IABS webina</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">31/01/2021</style></date></pub-dates></dates><publisher><style face="normal" font="default" size="100%">IABS</style></publisher><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>